Back to search

Article

Cell Model Representatives of Pediatric Neuroblastoma: Evidence from Transcriptomic Ranking and Pharmacogenomic Connectivity Analysis

2024-06-26

Abstract excerpt

<title>Abstract</title> <p>Background Neuroblastoma is the most common extracranial solid tumor among pediatric patients, with MYCN amplification marking a significant increase in mortality risk. The utilization of neuroblastoma cell lines serves as the first-line model for studying the phenotypic outcomes of novel therapeutic interventions. Selecting cell lines that closely mimic the molecular characteristics o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
336c3a04-56ec-5336-a2de-64703fcf3018
DOI
10.21203/rs.3.rs-4531254/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cell Model Representatives of Pediatric Neuroblastoma: Evidence from Transcriptomic Ranking and Pharmacogenomic Connectivity AnalysisDOI 10.21203/rs.3.rs-4531254/v1
Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic CompoundsSemantic proximity
Bioinformatic analysis of the inner heterogeneity within MYCN non-amplified pediatric neuroblastoma sub-groupSemantic proximity
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.Semantic proximity
Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasetsSemantic proximity
Integrative discovery of treatments for high-risk neuroblastomaSemantic proximity
A comparative network analysis of high-risk MYCN amplified and high-risk MYCN non-amplified neuroblastoma patientsSemantic proximity
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaSemantic proximity
NCAPG is a Potential Biomarker for Prognosis of Treatment in Children with High-risk NeuroblastomaSemantic proximity
Neuroblastoma, a Paradigm for Big Data Science in Pediatric OncologySemantic proximity
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studySemantic proximity
Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma.Semantic proximity
Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma TreatmentSemantic proximity
Select a neighboring publication to make it the new centre.